BR0008249A - Composição farmacêutica estável para aadministração intravenosa ou intramuscular deoctreotida - Google Patents

Composição farmacêutica estável para aadministração intravenosa ou intramuscular deoctreotida

Info

Publication number
BR0008249A
BR0008249A BR0008249-0A BR0008249A BR0008249A BR 0008249 A BR0008249 A BR 0008249A BR 0008249 A BR0008249 A BR 0008249A BR 0008249 A BR0008249 A BR 0008249A
Authority
BR
Brazil
Prior art keywords
intravenous
intramuscular administration
stable pharmaceutical
deoctreotide
pharmaceutical composition
Prior art date
Application number
BR0008249-0A
Other languages
English (en)
Inventor
Berta Ponsati Obiols
Gemma Jodas Farres
Francisco Javierclem Rodriguez
Sergi Pavon Fernandez
Jordi Bacarditcabado
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Publication of BR0008249A publication Critical patent/BR0008249A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Abstract

"COMPOSIçãO FARMACêUTICA ESTáVEL PARA AADMINISTRAçãO INTRAVENOSA OU INTRAMUSCULAR DEOCTREOTIDA".Composição farmacêutica estável para aadministração intravenosa ou intramuscular de octreotida que secaracteriza pelo fato de que como veículo para a injeção dopeptídeo ou seus sais farmaceuticamente aceitáveis, contémglicina a concentrações de 10mM a 60mM e solução aquosa deácido clorídrico em uma quantidade suficiente para ajustar o pH dafórmula a valores entre 3,0 e 4,2.
BR0008249-0A 1999-12-17 2000-12-15 Composição farmacêutica estável para aadministração intravenosa ou intramuscular deoctreotida BR0008249A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902769A ES2167189B1 (es) 1999-12-17 1999-12-17 Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
PCT/ES2000/000476 WO2001043776A1 (es) 1999-12-17 2000-12-15 Formulacion farmaceutica estable para la administracion intravenosa o intramuscular de octreotide

Publications (1)

Publication Number Publication Date
BR0008249A true BR0008249A (pt) 2001-10-30

Family

ID=8310959

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008249-0A BR0008249A (pt) 1999-12-17 2000-12-15 Composição farmacêutica estável para aadministração intravenosa ou intramuscular deoctreotida

Country Status (13)

Country Link
US (1) US6521599B2 (pt)
EP (1) EP1153615B1 (pt)
JP (1) JP4912551B2 (pt)
AT (1) ATE233105T1 (pt)
AU (1) AU763779B2 (pt)
BR (1) BR0008249A (pt)
CA (1) CA2362772C (pt)
DE (1) DE60001489T2 (pt)
DK (1) DK1153615T3 (pt)
ES (2) ES2167189B1 (pt)
MX (1) MXPA01008349A (pt)
PT (1) PT1153615E (pt)
WO (1) WO2001043776A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003293196A1 (en) * 2002-12-23 2004-07-29 Vical Incorporated Method for producing sterile polynucleotide based medicaments
PE20050285A1 (es) 2003-06-24 2005-06-09 Novartis Ag Composicion farmaceutica que comprende analogos ciclicos de somatostatina
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
JP2010538092A (ja) * 2007-09-07 2010-12-09 ユナイテッド セラピューティクス コーポレーション グラム陰性菌に対して選択的殺菌活性を有するバッファー溶液およびそれを使用する方法
CN102416001B (zh) * 2011-12-09 2013-06-05 重庆煜澍丰医药有限公司 一种注射用醋酸奥曲肽冻干粉针剂及其制备方法
CN111346214A (zh) * 2020-05-13 2020-06-30 吉林吉力生物技术研究有限公司 一种动物注射用醋酸奥曲肽冻干粉针剂及其制备方法和应用
CN114146054B (zh) * 2020-09-07 2022-12-02 深圳市健元医药科技有限公司 一种醋酸奥曲肽注射液的制备工艺
CN114288385B (zh) * 2021-12-27 2024-01-19 苏州天马医药集团天吉生物制药有限公司 一种醋酸奥曲肽制剂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3845000C2 (de) * 1987-07-10 1998-11-19 Novartis Ag Anwendung von Octreotid zur Behandlung von Brustkrebs
TW249202B (pt) * 1993-08-13 1995-06-11 Ciba Gerigy Corp
AU3257297A (en) * 1996-06-11 1998-01-07 Novartis Ag Combination of a somatostatin analogue and a rapamycin

Also Published As

Publication number Publication date
AU763779B2 (en) 2003-07-31
ES2193114T3 (es) 2003-11-01
DK1153615T3 (da) 2003-06-23
DE60001489D1 (de) 2003-04-03
CA2362772A1 (en) 2001-06-21
US6521599B2 (en) 2003-02-18
ES2167189A1 (es) 2002-05-01
WO2001043776A1 (es) 2001-06-21
PT1153615E (pt) 2003-06-30
ES2167189B1 (es) 2003-04-01
JP4912551B2 (ja) 2012-04-11
AU2173601A (en) 2001-06-25
JP2003517024A (ja) 2003-05-20
MXPA01008349A (es) 2004-03-19
CA2362772C (en) 2010-03-16
ATE233105T1 (de) 2003-03-15
EP1153615B1 (en) 2003-02-26
US20020128204A1 (en) 2002-09-12
EP1153615A1 (en) 2001-11-14
DE60001489T2 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
NO20022264L (no) Farmasoytisk blanding inneholdende tolterodin, samt anvendelse derav
ATE298561T1 (de) Orale dareichungsform
DK0550108T3 (da) Thyreoaktiv sammensætning med langvarig frigivelse
EA200700389A1 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
KR920019371A (ko) 안정화된 인자 ⅷ 제제
HUT75684A (en) Parenteral solutions of diclofenac salts
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
KR970061270A (ko) 히토성장호르몬을 함유하는 의약제제
HU9302007D0 (en) Method for producing pharmaceutical preparatives containing 2-|n-(2-amino-ethyl)-amino¨-acetic acid derivatives
BR0008249A (pt) Composição farmacêutica estável para aadministração intravenosa ou intramuscular deoctreotida
BR9913135A (pt) Formulação oral
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
DE69615984D1 (de) Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen
WO2002042414A3 (en) Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
JPS6416724A (en) Stable and injectable vinca dimer salt solution
DE69430416T2 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
ES2242973T3 (es) Utilizacion de antagonistas peptidicos de bradiquinina para la preparacion de medicamentos.
EP0296227A1 (en) Nasal delivery of amino acids
SE0000782D0 (sv) Pharmaceutical formulation and its use
IT9048063A1 (it) Composizioni farmaceutiche a base di calcitonina somministrabili per via nasale

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 47/18

Ipc: A61K 47/18 (2011.01), A61K 38/31 (2011.01), A61P 5

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B25A Requested transfer of rights approved

Owner name: GP-PHARM, S.A. (ES)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 15A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI